GSK Investigational Site

Cona (Ferrara), Emilia-Romagna 44124

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Infection, Human Immunodeficiency Virus I

Studies at this site

• A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily — Completed
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed